Profile

JN Nova Pharma is a Canadian biotech company collaborating with the National Research Council of Canada’s Human Health scientists to develop promising therapeutics for COVID, long COVID, acute respiratory distress syndrome (ARDS) and acute kidney injury (AKI). JN Nova Pharma is planning to enter clinic in 2024. At the Biotech Showcase, JN Nova  Pharma eagerly explores additional regional strategic global partnerships, seeking co-develoments partners to accelerate clinical development and deliver lifesaving medicines to patients globally.

JN Nova Pharma Inc. logo

Website

jnnova.com

Contact


Event details

Date: September 25 - 27, 2024

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences

Participants

13 in total